Przejdź do głównej treści
Wersja kontrastowa
en English Menu
"

Widok zawartości stron Widok zawartości stron

Pomiń baner

Rekrutacje grantowe

Konwersatoria

Konkursy ID.UJ

Dla Doktorantów

Nawigacja okruszkowa Nawigacja okruszkowa

Widok zawartości stron Widok zawartości stron

Head of the PhD study programme:

dr hab. Piotr Rozpądek, Prof. UJ
phone: +48 12 664 6108
e-mail: piotr.rozpadek@uj.edu.pl

PhD Student Administration Office:

mgr Magdalena Pisarczyk
phone: +48 453 672 171
magdalena.pisarczyk@uj.edu.pl

 

Limits of places
[regular recruitment] 2023/24:

1st round (June/July):

MCB: 1
JCET: 2
Solaris: 2

2nd round (September):

MCB: 3
JCET: 0
Solaris: 1

3rd round (October/November):

MCB: 2
JCET: 0
Solaris: 0

Admission:

Admission rules
Admission rules [PL version]
Required documents
Required documents [PL version]
Schedule

Apply via: Online Application System

Past calls:

List of past calls

Widok zawartości stron Widok zawartości stron

>>PhD study programme in Biomedical Sciences<< v. 22/23  [eight-terms]
>>PhD study programme in Biomedical Sciences << v. 22/23 [six-terms]

List of potential PhD advisors [MCB]

PhD Programme in Biomedical Sciences is a programme at the Doctoral School of Exact and Natural Sciences the Jagiellonian University in Krakow with a strong inter-disciplinary, international inter-sectoral research and training dimension.

We will recruit early stage researchers (ESRs) in an open call, targeting the most talented and motivated ESRs in the fields of Biological and Medical Sciences. The recruitment process will adhere to the guidelines set in the code of conduct for the recruitment of researchers and the European charter for researchers, ensuring transparency of the recruitment process based on the merit and skills of applicants. The recruitment process will not discriminate applicants based on their personal features.
Training will be focused on the interest and expertise of researchers working at the Malopolska Centre of Biotechnology (MCB), Jagiellonian Centre for Experimental Therapeutics (JCET) and National Synchrotron Radiation Centre (SOLARIS).
The program covers various areas of biology:

  • synthetic,
  • structural,
  • molecular,
  • cellular,
  • developmental

and utilizes plants, viruses, bacteria, invertebrates and vertebrates.
The program is also linked to interdisciplinary studies in endothelial biomedicine. 

Our Students offered a place in our PhD programme will obtain a full scholarship funded by the Polish government regardless of nationality.
The applicants are free to choose the research topic and supervisors from the focus areas based on their personal interests and qualifications. We encourage our students to get involved in the broad range of scientific activities of MCB, JCET and Solaris research groups. It is also an excellent opportunity to learn to think across disciplines and build up initial collaborations and cross-disciplinary skill sets.
The programme is run in English, either in a six-semester or in an eight-semester system.
During their studies, our students are expected to attend training courses in transferable and general research skills, participate in the students' and outreach activities, present their work regularly and attend seminars.

Widok zawartości stron Widok zawartości stron

J2. Studies on the role of energy metabolism in the activity and function of blood platelets in hyperglycaemia and atherosclerosis (dr hab. Patrycja Kaczara)

Supervisor: dr hab. Patrycja Kaczara

Jagiellonian Centre for Experimental Therapeutics

Project description:

Thrombosis, which is associated with various cardiovascular diseases, is one of the leading clinical concerns associated with high morbidity and mortality. Importantly, blood platelets in patients with metabolic diseases often exhibit hyperreactivity, leading to an increased risk of cardiovascular events related to thrombosis. Despite antithrombotic treatment, the risk of such events is not eliminated; furthermore, unwanted side effects, such as bleeding, may occur. Platelet aggregation is an energy-demanding process that can be supported by ATP provided by both glycolysis and mitochondrial respiration [1, 2]. Most commonly used antiplatelet drugs are directed toward targets that do not affect energy metabolism, therefore current antiplatelet strategies may not provide optimal inhibition of platelet hyperreactivity. It is known that beyond ATP production, cellular metabolism controls the fate of cells. However, it is not yet clear how the imbalance between the cytosolic and mitochondrial energy metabolism processes affects the activity of blood platelets.

The central hypothesis of the project is that reprogramming platelet energy metabolism enhances the action of selected antiplatelet drugs under the conditions of hyperglycaemia and atherosclerosis. The aim of the project is to explore the metabolic processes responsible for the development of platelet hyperreactivity and to investigate how combined treatment with selected antiplatelet drugs and metabolic inhibitors affects platelet energy metabolism and activity. Pharmacological modulation of metabolic pathways will be a tool for observing changes at the molecular, organellar and cellular levels by analysing metabolic fluxes, ROS and calcium signaling, mitochondrial quality control, and platelet function. The results of the project are expected to identify new metabolic targets for the development of innovative antiplatelet therapies that protect against or decrease thrombosis.

References:

[1] Kaczara et al. “Antiplatelet effect of carbon monoxide is mediated by NAD+ and ATP depletion” Arteeriosclerosis, Thrombosis, and Vascular Biology 2020; 40:2376-2390

[2] Flora et al. “Metabolic targeting of platelets to combat thrombosis: down of a new paradigm?” Cardiovascular Research, 2023; 119:2497-2507

Scope of work:

Basic Focus: Examination of activity, aggregatory potential and energy metabolism of blood platelets.

  • Design, prepare and conduct experiments on isolated blood platelets in vitro.
  • Conducting functional in vitro assays for analysis of platelet activation, aggregation, and energy metabolism.
  • Investigation of interactions between antiplatelet drugs and inhibitors of energy metabolism pathways.

Objective: Improve the understanding of the crosstalk between platelet reactivity and energy metabolism.

Required professional qualifications:

  • The PhD student must hold Master's degree in Life Sciences discipline.
  • The selected candidate should have practical laboratory experience, supported by references of the academic tutor and qualifications and suitability for research.
  • The PhD students should have very good knowledge of English (written and spoken), be ready to learn new techniques, attending courses and be creative with good and responsible attitude, multitasking approach, and good organizational capacity.